Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. 3-((2-aminoethoxy)imino)androstane-6,17-dione
2. 3-((2-aminoethoxy)imino)androstane-6,17-dione Hydrochloride
3. Pst 2744
4. Pst-2744
5. Pst2744
1. 203737-93-3
2. Istaroxime, (e)-
3. Pst-2744
4. W40687go3s
5. (3e,5s,8r,9s,10r,13s,14s)-3-(2-aminoethoxyimino)-10,13-dimethyl-1,2,4,5,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthrene-6,17-dione
6. 203738-46-9
7. 3-((2-aminoethoxy)imino)-5alpha-androstan-6,17-dione
8. Debio-0614
9. Istaroxime [inn]
10. Unii-w8i9h2tppl
11. Pst 2744
12. St-2744
13. W8i9h2tppl
14. Unii-w40687go3s
15. Chembl469045
16. Schembl7285904
17. Dtxsid20870222
18. Akos024259258
19. Cs-1531
20. Db06157
21. Ac-36855
22. As-78198
23. Hy-15718
24. 5-alpha-androstan-6,17-dione, 3-((2-aminoethoxy)imino)-
25. Androstane-3,6,17-trione, 3-(o-(2-aminoethyl)oxime), (3e,5alpha)-
26. Androstane-3,6,17-trione, 3-(o-(2-aminoethyl)oxime), (3e,5.alpha.)-
| Molecular Weight | 360.5 g/mol |
|---|---|
| Molecular Formula | C21H32N2O3 |
| XLogP3 | 1.5 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 3 |
| Exact Mass | 360.24129289 g/mol |
| Monoisotopic Mass | 360.24129289 g/mol |
| Topological Polar Surface Area | 81.8 Ų |
| Heavy Atom Count | 26 |
| Formal Charge | 0 |
| Complexity | 645 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 6 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 1 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Investigated for use/treatment in heart disease.
Reduces the sodium-potassium adenosine triphosphatase (ATPase) activity and stimulates the sarcoplasmic calcium ATPase isoform 2 reuptake function.
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
ABOUT THIS PAGE
97
PharmaCompass offers a list of Istaroxime API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Istaroxime manufacturer or Istaroxime supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Istaroxime manufacturer or Istaroxime supplier.
PharmaCompass also assists you with knowing the Istaroxime API Price utilized in the formulation of products. Istaroxime API Price is not always fixed or binding as the Istaroxime Price is obtained through a variety of data sources. The Istaroxime Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Istaroxime manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Istaroxime, including repackagers and relabelers. The FDA regulates Istaroxime manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Istaroxime API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Istaroxime supplier is an individual or a company that provides Istaroxime active pharmaceutical ingredient (API) or Istaroxime finished formulations upon request. The Istaroxime suppliers may include Istaroxime API manufacturers, exporters, distributors and traders.
Istaroxime Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Istaroxime GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Istaroxime GMP manufacturer or Istaroxime GMP API supplier for your needs.
A Istaroxime CoA (Certificate of Analysis) is a formal document that attests to Istaroxime's compliance with Istaroxime specifications and serves as a tool for batch-level quality control.
Istaroxime CoA mostly includes findings from lab analyses of a specific batch. For each Istaroxime CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Istaroxime may be tested according to a variety of international standards, such as European Pharmacopoeia (Istaroxime EP), Istaroxime JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Istaroxime USP).
